Gilead Sciences (GILD) Gross Margin Growth (5y) (2014 - 2026)

Gilead Sciences (GILD) Gross Margin Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 43.00
Dec 31, 2025 -165.00
Sep 30, 2025 -285.00
Jun 30, 2025 -51.00
Mar 31, 2025 -563.00
Dec 31, 2024 774.00
Sep 30, 2024 -239.00
Jun 30, 2024 -461.00
Mar 31, 2024 -509.00
Dec 31, 2023 -229.00
Sep 30, 2023 -279.00
Jun 30, 2023 -68.00
Mar 31, 2023 -238.00
Dec 31, 2022 222.00
Sep 30, 2022 -396.00
Jun 30, 2022 -727.00
Mar 31, 2022 -690.00
Dec 31, 2021 -2,158.00
Sep 30, 2021 -143.00
Jun 30, 2021 -1,125.00